In this study, we investigated the therapeutic potential of simultaneously targeting two protein families critical for proliferation and survival of cancer cells—the bromodomain and extra-terminal domain (BET) protein family of transcriptional regulators and inhibitors of apoptosis proteins (IAPs). Here, DNER is linked to cancer.